Viral infections and invasive group A streptococcal disease incidence during 2022–2023 – authors' reply
We thank dr. Lear, dr. Sriskandan and dr. Parks for their thoughtful comments1 on our study and for highlighting several important considerations when interpreting ecological analyses of viral activity and invasive Streptococcus pyogenes (iGAS) incidence and welcome the opportunity to clarify several methodological points.
Authors
- Naïm Ouldali (ORCID: https://orcid.org/0000-0003-4996-9640)
- Ruud Nijman (ORCID: https://orcid.org/0000-0001-9671-8161)
- Léa Lenglart (ORCID: https://orcid.org/0000-0003-2325-8998)
- Dorine Borensztajn
- Izel Özmen
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Northwest Hospital (US)
- NIHR Imperial Biomedical Research Centre (GB)
- St Mary's Hospital (GB)
- Hôpital Robert-Debré (FR)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Imperial College London (GB)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101583
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00